8576 - 8600 of 9033 Results
Title
Year
-
OPENTitle: The longitudinal associations between cognition, mood and striatal dopaminergic binding in Parkinson’s DiseaseJournal Name: Aging, Neuropsychology, and CognitionPublisher: Informa UK LimitedVol: 27Issue #: 4Start Page: 581End Page: 594Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/13825585.2019.1653445Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8763139Citation Count: 24
-
OPENTitle: Defining α-synuclein species responsible for Parkinson’s disease phenotypes in miceJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 294Issue #: 27Start Page: 10392End Page: 10406Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.ra119.007743Best OA location URL: http://www.jbc.org/article/S0021925820318330/pdfCitation Count: 131
- Diverse paths of phenotypic evolution in functional movement disorders: A longitudinal perspective2025RESTRICTEDTitle: Diverse paths of phenotypic evolution in functional movement disorders: A longitudinal perspectiveJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 144Issue #:Start Page: 108059End Page: 108059Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108059Citation Count: 1
- Increased substantia nigra echogenicity in LRRK2 family members without mutations2018RESTRICTEDTitle: Increased substantia nigra echogenicity in LRRK2 family members without mutationsJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 9Start Page: 1504End Page: 1505Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27443Citation Count: 2
-
OPENTitle: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed CellsJournal Name: Angewandte ChemiePublisher: WileyVol: 135Issue #: 40Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ange.202309306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ange.202309306Citation Count: 1
- A biobank for Parkinson's disease and atypical parkinsonism in central Asian and Transcaucasian regions2024RESTRICTEDTitle: A biobank for Parkinson's disease and atypical parkinsonism in central Asian and Transcaucasian regionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 23Issue #: 9Start Page: 859End Page: 860Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00313-2Citation Count: 4
-
OPENTitle: Functional connectivity disruptions correlate with cognitive phenotypes in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 14Issue #:Start Page: 591End Page: 601Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.03.002Best OA location URL: https://doi.org/10.1016/j.nicl.2017.03.002Citation Count: 109
-
OPENTitle: Diagnostic classification of Parkinson’s disease based on non-motor manifestations and machine learning strategiesJournal Name: Neural Computing and ApplicationsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 8Start Page: 5603End Page: 5617Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00521-022-07256-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00521-022-07256-8.pdfCitation Count: 50
- Novel regulators of heparan sulfate proteoglycans modulate cellular uptake of α-synuclein fibrils2025OPENTitle: Novel regulators of heparan sulfate proteoglycans modulate cellular uptake of α-synuclein fibrilsJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 1426End Page: 1426Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-025-08786-2Best OA location URL: https://www.nature.com/articles/s42003-025-08786-2.pdfCitation Count: 3
-
OPENTitle: Altered Neural Activation in First Episode Psychosis Patients With Comorbid Conduct Disorder: A Pilot InvestigationJournal Name: JAACAP OpenPublisher: Elsevier BVVol: 3Issue #: 1Start Page: 101End Page: 113Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jaacop.2024.04.001Best OA location URL: http://www.jaacapopen.org/article/S2949732924000310/pdfCitation Count: 1
- Hypertension and progressive supranuclear palsy2019RESTRICTEDTitle: Hypertension and progressive supranuclear palsyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 66Issue #:Start Page: 166End Page: 170Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.07.036Citation Count: 24
-
OPENTitle: Longitudinal assessment of DNA repair signature trajectory in prodromal versus established Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 349End Page: 349Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-025-01194-7Best OA location URL: https://www.nature.com/articles/s41531-025-01194-7.pdfCitation Count: 1
- Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson Disease2016RESTRICTEDTitle: Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson DiseaseJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 88Issue #: 3Start Page: 1856End Page: 1863Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.analchem.5b04227Citation Count: 83
-
OPENTitle: LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neuronsJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 30Issue #: 10Start Page: 4473End Page: 4486Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41380-025-03030-zBest OA location URL: https://www.nature.com/articles/s41380-025-03030-z.pdfCitation Count: 6
-
OPENTitle: The cross-linking activity of transglutaminase 2 drives α-Synuclein pathology in synucleinopathy modelsJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 123Issue #: 12Start Page: e2517886123End Page: e2517886123Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.2517886123Best OA location URL: https://doi.org/10.1073/pnas.2517886123Citation Count: 0
-
OPENTitle: Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer DiseaseJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 80Issue #: 3Start Page: 240End Page: 246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlaa160Best OA location URL: https://academic.oup.com/jnen/article-pdf/80/3/240/36335359/nlaa160.pdfCitation Count: 23
-
OPENTitle: PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson’s disease modelsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 149Issue #: 4Start Page: 1289End Page: 1301Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaf372Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awaf372/64714714/awaf372.pdfCitation Count: 2
-
OPENTitle: NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug‐inducible neuroprotection from oxidative stressJournal Name: The FASEB JournalPublisher: WileyVol: 33Issue #: 10Start Page: 11223End Page: 11234Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1096/fj.201900830rBest OA location URL: https://doi.org/10.1096/fj.201900830rCitation Count: 129
-
OPENTitle: CSF Aβ42 and tau in Parkinson's disease with cognitive impairmentJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2682End Page: 2685Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23287Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978754Citation Count: 181
-
OPENTitle: Ade novocompound targeting α-synuclein improves deficits in models of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 139Issue #: 12Start Page: 3217End Page: 3236Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/aww238Best OA location URL: https://academic.oup.com/brain/article-pdf/139/12/3217/24173157/aww238.pdfCitation Count: 156
- Association of Neurological Family Health History in Parkinson's Diseases2024RESTRICTEDTitle: Association of Neurological Family Health History in Parkinson's DiseasesJournal Name: 2024 International Conference on Brain Computer Interface & Healthcare Technologies (iCon-BCIHT)Publisher: IEEEVol:Issue #:Start Page: 207End Page: 212Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/icon-bciht63907.2024.10882367Citation Count: 1
-
OPENTitle: Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathiesJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 28Issue #: 4Start Page: 548End Page: 560Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddy365Best OA location URL: https://academic.oup.com/hmg/article-pdf/28/4/548/27636558/ddy365.pdfCitation Count: 80
-
OPENTitle: PREFACE: Divergent roles of ER stress in neurodegeneration and brain disordersJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 527End Page: 529Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.brainres.2016.09.014Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0006899316306229?via%3DihubCitation Count: 1
-
OPENTitle: Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsiesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page: 35End Page: 35Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-016-0305-8Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-016-0305-8Citation Count: 71
-
OPENTitle: Fine‐Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt SynucleinopathiesJournal Name: Annals of NeurologyPublisher: WileyVol: 87Issue #: 4Start Page: 584End Page: 598Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25687Best OA location URL: http://hdl.handle.net/11380/1205937Citation Count: 63